This finding is in good agreement with the recent PROFILE (Prospective Observation of Fibrosis in the Lung Clinical Endpoints) study results indicating that serum SP-D and MMP-7 could best discriminate between IPF patients and controls based on the analysis of 44 proteins differentially expressed in a large IPF cohort and control subjects. This evidence concerns the gene SFTPD and fibrosis.